{
    "root": "2f9eed08-35aa-d323-e063-6294a90a63a9",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Amoxicillin",
    "value": "20250305",
    "ingredients": [
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "AMOXICILLIN",
            "code": "804826J2HU"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3"
        }
    ],
    "indications": "adults pediatric patients upper respiratory tract infections ear , nose , throat amoxicillin indicated treatment infections due susceptible ( \u03b2-lactamase\u2013negative ) isolates streptococcusspecies . ( \u03b1- \u03b2-hemolytic isolates ) , streptococcus pneumoniae , staphylococcus spp . , haemophilus influenzae . infections genitourinary tract amoxicillin indicated treatment infections due susceptible ( \u03b2-lactamase\u2013negative ) isolates escherichia coli , proteus mirabilis , enterococcus faecalis . infections skin skin structure amoxicillin indicated treatment infections due susceptible ( \u03b2-lactamase\u2013negative ) isolates streptococcus spp . ( \u03b1- \u03b2-hemolytic isolates ) , staphylococcus spp . , e. coli . infections lower respiratory tract amoxicillin indicated treatment infections due susceptible ( \u03b2-lactamase\u2013negative ) isolates streptococcus spp . ( \u03b1- \u03b2-hemolytic isolates ) , s. pneumoniae , staphylococcus spp . , h. influenzae . adult patients helicobacter pyloriinfection duodenal ulcer disease triple therapy helicobacter pylori ( h.pylori ) clarithromycin lansoprazole amoxicillin , combination clarithromycin plus lansoprazole triple therapy , indicated treatment patients h. pyloriinfection duodenal ulcer disease ( active 1-year history duodenal ulcer ) eradicate h. pylori.eradication h. pylorihas shown reduce risk duodenal ulcer recurrence . dual therapy h. pylori lansoprazole amoxicillin , combination lansoprazole delayed-release capsules dual therapy , indicated treatment patients h. pyloriinfection duodenal ulcer disease ( active 1-year history duodenal ulcer ) either allergic intolerant clarithromycin resistance clarithromycin known suspected . ( clarithromycin package insert , microbiology . ) eradication h. pylorihas shown reduce risk duodenal ulcer recurrence . usage reduce development drug-resistant bacteria maintain effectiveness amoxicillin antibacterial drugs , amoxicillin used treat infections proven strongly suspected caused bacteria . culture susceptibility information available , considered selecting modifying antibacterial therapy . absence data , local epidemiology susceptibility patterns may contribute empiric selection therapy .",
    "contraindications": "click tap enter text .",
    "warningsAndPrecautions": "amoxicillin capsules , usp , oral , contain 250 mg amoxicillin trihydrate supplied : 250 mg : yellow , opaque , hard gelatin capsules imprinted amox 250 one side gg 848 side . ndc : 70518-2188-00 packaging : 30 1 blister pack store capsules , tablets unreconstituted powder oral suspension 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) . [ usp controlled room temperature ] . dispense tight container . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "amoxicillin contraindicated patients experienced serious hypersensitivity reaction ( e.g . , anaphylaxis stevens-johnson syndrome ) amoxicillin \u03b2-lactam antibacterial drugs ( e.g . , penicillins cephalosporins ) .",
    "indications_original": "Adults and Pediatric Patients\n                  \n                  \n                     \n                        Upper Respiratory Tract Infections of the Ear, Nose, and Throat\n                     \n                  \n                  Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY \u03b2-lactamase\u2013negative) isolates of\n \n  Streptococcusspecies. (\u03b1- and \u03b2-hemolytic isolates only),\n \n  Streptococcus pneumoniae,\n \n  Staphylococcus spp., or\n \n  Haemophilus influenzae.\n                  \n                  \n                     \n                        Infections of the Genitourinary Tract\n                     \n                  \n                  Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY \u03b2-lactamase\u2013negative) isolates of\n \n  Escherichia coli, Proteus mirabilis, or Enterococcus faecalis.\n                  \n                  \n                     \n                        Infections of the Skin and Skin Structure\n                     \n                  \n                  Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY \u03b2-lactamase\u2013negative) isolates of\n \n  Streptococcus spp.(\u03b1- and \u03b2-hemolytic isolates only),\n \n  Staphylococcus spp., or E. coli.\n                  \n                  \n                     \n                        Infections of the Lower Respiratory Tract\n                     \n                  \n                  Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY \u03b2-lactamase\u2013negative) isolates of\n \n  Streptococcus spp.(\u03b1- and \u03b2-hemolytic isolates only),\n \n  S. pneumoniae, Staphylococcus spp.,or\n \n  H. influenzae.\n                  \n                  \n                     Adult Patients Only\n                  \n                  \n                     \n                        \n                           Helicobacter pyloriInfection and Duodenal Ulcer Disease\n  \n   \n                     \n                  \n                  \n                     \n                        Triple therapy for Helicobacter pylori (H.pylori) with clarithromycin and lansoprazole\n                     \n                  \n                  Amoxicillin, in combination with clarithromycin plus lansoprazole as triple therapy, is indicated for the treatment of patients with\n \n  H. pyloriinfection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer) to eradicate\n \n  H. pylori.Eradication of\n \n  H. pylorihas been shown to reduce the risk of duodenal ulcer recurrence.\n\n \n                  \n                     \n                        Dual therapy for H. pylori with lansoprazole\n                     \n                  \n                  Amoxicillin, in combination with lansoprazole delayed-release capsules as dual therapy, is indicated for the treatment of patients with\n \n  H. pyloriinfection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer)\n \n  who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected.(See the clarithromycin package insert, MICROBIOLOGY.) Eradication of\n \n  H. pylorihas been shown to reduce the risk of duodenal ulcer recurrence.\n\n \n                  \n                     Usage\n                  \n                  To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.",
    "contraindications_original": "Click or tap here to enter text.",
    "warningsAndPrecautions_original": "Amoxicillin Capsules, USP,\u00a0for oral administration, contain 250 mg amoxicillin as the trihydrate and are supplied as:\n                  250 mg:\u00a0yellow, opaque, hard gelatin capsules imprinted AMOX 250 on one side and GG 848 on the other side.\n                  \n                  NDC: 70518-2188-00\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Store capsules, tablets and unreconstituted powder for oral suspension at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F). [See USP Controlled Room Temperature].\u00a0Dispense in a tight container.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Amoxicillin is contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin or to other \u03b2-lactam antibacterial drugs (e.g., penicillins and cephalosporins)."
}